Prognostic value of HIF-1a expression in patients with gastric cancer

Molecular Biology Reports

Volumn 40, Issue 11, 2013, Pages 6055-6062

  Zhu, Cheng Lin ^a   Huang, Qiang ^a   Liu, Chen Hai ^a   Lin, Xian Sheng ^a   Xie, Fang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; HIF 1a; Meta analysis; Prognosis

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; ASIAN; CANCER PROGNOSIS; CANCER SURVIVAL; GENETIC HETEROGENEITY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RACE DIFFERENCE; SENSITIVITY ANALYSIS; STOMACH CANCER; SURVIVAL RATE; SYSTEMATIC REVIEW; UPREGULATION; VASCULAR TUMOR;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; PUBLICATION BIAS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887697777     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2715-z     Document Type: Article

References (34)

1. Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893-2917
2. Amedei A, Benagiano M, della Bella C et al (2011) Novel immunotherapeutic strategies of gastric cancer treatment. J Bio-med Biotechnol 2011:437348
3. Keighley MR (2003) Gastrointestinal cancers in Europe. Aliment Pharmacol Ther 18(Suppl 3):7-30
4. Xing X, Tang YB, Yuan G et al (2012) The prognostic value of E-cadherin in gastric cancer: A meta-analysis. Int J Cancer
5. Zhang QW, Liu L, Chen R et al (2012) Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev 13(6):2903-2908
6. Liu L, Ma XL, Xiao ZL et al (2012) Prognostic value of vascular endothelial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev 13(7):3089-3097
7. O'Rourke JF, Dachs GU, Gleadle JM et al (1997) Hypoxia response elements. Oncol Res 9(6-7):327-332
8. Rohwer N, Cramer T (2010) HIFs as central regulators of gastric cancer pathogenesis. Cancer Biol Ther 10(4):383-385
9. Zagzag D, Zhong H, Scalzitti JM et al (2000) Expression of hypoxia-inducible factor 1 alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88(11):2606-2618
10. Theodoropoulos VE, Lazaris ACh, Sofras F et al (2004) Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 46(2): 200-208
11. Bos R, Zhong H, Hanrahan CF et al (2001) Levels of hypoxia-inducible factor 1 alpha during breast carcinogenesis. J Natl Cancer Inst 93(4):309-314
12. Kuwai T, Kitadai Y, Tanaka S et al (2003) Expression of hypoxia-inducible factor 1 alpha is associated with tumor vas-cularization in human colorectal carcinoma. Int J Cancer 105(2):176-181
13. Bos R, van der Groep P, Greijer AE et al (2003) Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97(6):1573-1581
14. Kurokawa T, Miyamoto M, Kato K et al (2003) Overexpression of hypoxia-inducible-factor 1 alpha (HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer 89(6):1042-1047
15. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17(24):2815-2834
16. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539-1558
17. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109): 629-634
18. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4): 1088-1101
19. Mizokami K, Kakeji Y, Oda S et al (2006) Relationship of hypoxia-inducible factor 1alpha and p21WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer. World J Surg Oncol 4:94
20. Cabuk D, Basaran G, Celikel C et al (2007) Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival. Oncology 72(1-2):111-117
21. Nakamura J, Kitajima Y, Kai K et al (2009) Hypoxia-inducible factor-1alpha expression predicts the response to 5-fluorouracil-based adjuvant chemotherapy in advanced gastric cancer. Oncol Rep 22(4):693-699
22. Nakamura J, Kitajima Y, Kai K et al (2010) HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy. Int J Cancer 127(5):1158-1171
23. Woo S, Lee BL, Yoon J et al (2011) Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1a in human gastric cancer. Pathobiology 78(6):295-301
24. Mizokami K, Kakeji Y, Oda S et al (2006) Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 94(2):149-154
25. Sumiyoshi Y, Kakeji Y, Egashira A et al (2006) Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 12(17): 5112-5117
26. Urano N, Fujiwara Y, Doki Y et al (2006) Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer 9(1):44-49
27. Ma J, Zhang L, Ru GQ et al (2007) Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angio-genesis and predicts a poor prognosis in gastric carcinoma. World J Gastroenterol 13(11):1680-1686
28. Griffiths EA, Pritchard SA, Valentine HR et al (2007) Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer 96(1):95-103
29. Oh SY, Kwon HC, Kim SH et al (2008) Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preop-erative serum VEGF level in gastric cancer. BMC Cancer 8:123
30. Kolev Y, Uetake H, Takagi Y et al (2008) Lactate dehydroge-nase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol 15(8): 2336-2344
31. Qiu MZ, Han B, Luo HY et al (2011) Expressions of hypoxia-inducible factor-1a and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features. Tumour Biol 32(1):159-166
32. Isobe T, Aoyagi K, Koufuji K et al (2012) Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1a) expression in gastric cancer. Int J Clin Oncol
33. Stoeltzing O, McCarty MF, Wey JS et al (2004) Role of hypoxia-inducible factor 1 alpha in gastric cancer cell growth, angio-genesis, and vessel maturation. J Natl Cancer Inst 96(12): 946-956
34. Malats N, Bustos A, Nascimento CM et al (2005) P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol 6(9):678-686